Menu
Content/Inhalt
Home
|
Careers
|
Contact us
Search
Welcome
History
Social responsibility
Our companies
Debiopharm Group
Debiopharm S.A.
Debio R.P. S.A.
Debioclinic S.A.
Debiovision Inc.
Debioinnovation S.A.
Business Model
Strengths
Development capabilites
Preclinical
Clinical
Manufacturing
Regulatory
Innovative drug delivery and formulation
Partnering
Licensing-in
Licensing-out
Partners
Pipeline
Commercial Products
Eloxatin®
Decapeptyl®
News & Events
Press Releases
Awards
Publications
Conferences
News
02.09.2008
Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate For Cancer Treatment
21.08.2008
Doctor Manel Esteller Receives the Debiopharm Life Sciences Award For his Outstanding Research in Epigenetic Oncology
Home
News & Events
Publications
Triptorelin / Decapeptyl / Trelstar
Order
Date asc
Date desc
Title asc
Title desc
Ordering
Display #
5
10
15
20
25
30
50
Date
Item Title
31-Jul-2003
Comparative Efficacy of Triptorelin Pamoate and Leuprolide Acetate in Men with Advanced Prostate Cancer
30-Dec-2001
Phase II trial with triptorelin in prostatic carcinoma
30-Dec-2001
A phase II trial with New Triptorelin Sustained Release formulations in Prostatic Carcinoma
30-Dec-2000
Effects of an extended-interval Dosing Regimen of Triptorelin Depot on the Hormonal Profile of Patients with Endometriosis (prospective observational study)
30-Dec-2000
A Crossover Study of Triptorelin and Leuprorelin Acetate
< Prev
1
2
Next >
Results 1 - 5 of 7
Debio 025
( 28 items )
Oxaliplatin – Eloxatin – Elplat
( 12 items )
Debio 9902 - ZT-1
( 8 items )
Debio 8609 Sanvar
( 1 items )
Archives
( 15 items )